Electroencephalographic Neonatal Seizures: Clinical Trials

1 trial for Electroencephalographic Neonatal Seizures, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Electroencephalographic Neonatal Seizures: new trials by email Literature Review of Electroencephalographic Neonatal Seizures trials Research Report on Electroencephalographic Neonatal Seizures

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures
Brivaracetam (BRV) intravenous (iv), Brivaracetam (BRV) oral - Electroencephalographic Neonatal Seizures
Phase 3TerminatedUCB Biopharma SRL92019-05-072024-04-08

Narrower conditions

Epilepsy (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Nervous System Diseases (1)

Interventions

brivaracetam (1)

Sponsors

UCB Biopharma SRL (1)

Countries

Belgium (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Italy (1)  ·  United Kingdom (1)

Results publications

PMID 38049197

NIH funding

2015 (1)